3mg of retatrutide New Phase 3 data dropped and everyone's running with the big number. 30% body weight loss at 12mg. Impressive headline. But nobody's talking about 4mg. π 19% body weight loss π Retatrutide Subcutaneous Fat Loss Results:
Description
The bottom line Glucagon-like peptide-1 receptor agonist medications (GLP-1s) aren't FDA-approved to treat high blood pressure
S., McGuire, D
Anyone considering retatrutide or any other unlicensed weight-loss medicine should be aware that doing so falls outside NHS-supported care pathways and may carry significant, unpredictable health risks
If you develop symptoms such as unusual fatigue, muscle weakness, numbness or tingling, hair loss, or mood changes, contact your GP as these may indicate nutritional deficiencies requiring investigation and targeted treatment
As is increasingly the case, research like this is a race against time
Mantenga todos los medicamentos fuera del alcance de nios y mascotas
